Snk Pharma Limited
07760088
Healthy
No risk factors detected.
Details
Compliance
Last accounts
30/09/2024
unaudited abridged
Next accounts due
30/06/2026
Confirmation statement
Last: 15/08/2025
Due 29/08/2026
Industry
Officers
director · Since 02/09/2011
DIRECTOR
BRITISH · ENGLAND · Age 38
Also on 5 other boards
Persons with Significant Control
Mr Sohail Naseem Khan
British · England · Age 38
23, Dearman Road, Birmingham, B11 1HH
Notified 01/07/2016
Change History
Active
Private Limited Company
23 DEARMAN ROAD
BIRMINGHAM
CompanyRankvs 4068+ SIC 86900 peers79
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/09/2025
Net Worth
£14k
Balance sheet strength
Cash
£6k
Cash in the bank
Net Current Assets
£44k
Working capital
Current Assets
£55k
Current Liabilities
£12k
Fixed Assets
£2
Debtors
£49k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 4.70 | -£3k |
| 2024 | 13.64 | +£14k |
| 2023 | 4.96 | — |
Derived from filed accounts. Not audited figures.